Technical Analysis for VXRT - Vaxart, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical VXRT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | -6.92% | |
| Wide Bands | Range Expansion | -6.92% | |
| Gapped Down | Weakness | -6.92% | |
| 180 Bearish Setup | Bearish Swing Setup | -17.09% | |
| Narrow Range Bar | Range Contraction | -17.09% | |
| NR7 | Range Contraction | -17.09% | |
| Inside Day | Range Contraction | -17.09% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Down 10% | about 5 hours ago | |
| 60 Minute Opening Range Breakdown | about 6 hours ago | |
| Rose Above Upper Bollinger Band | about 10 hours ago | |
| Down 5% | about 10 hours ago | |
| Down 3% | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2019
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Coronavirus Hepatitis B Vaccine Vaccination Infectious Causes Of Cancer Papillomavirus HPV Human Papillomavirus Infection Seasonal Influenza Human Papilloma Virus
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Coronavirus Hepatitis B Vaccine Vaccination Infectious Causes Of Cancer Papillomavirus HPV Human Papillomavirus Infection Seasonal Influenza Human Papilloma Virus
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.9 |
| 52 Week Low | 1.08 |
| Average Volume | 16,656,740 |
| 200-Day Moving Average | 7.12 |
| 50-Day Moving Average | 8.00 |
| 20-Day Moving Average | 7.71 |
| 10-Day Moving Average | 7.01 |
| Average True Range | 1.31 |
| ADX | 22.84 |
| +DI | 28.32 |
| -DI | 28.38 |
| Chandelier Exit (Long, 3 ATRs ) | 20.96 |
| Chandelier Exit (Short, 3 ATRs ) | 9.62 |
| Upper Bollinger Band | 9.53 |
| Lower Bollinger Band | 5.89 |
| Percent B (%b) | 0.01 |
| BandWidth | 47.23 |
| MACD Line | -0.62 |
| MACD Signal Line | -0.38 |
| MACD Histogram | -0.2336 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.96 | ||||
| Resistance 3 (R3) | 7.00 | 6.70 | 6.78 | ||
| Resistance 2 (R2) | 6.70 | 6.44 | 6.68 | 6.72 | |
| Resistance 1 (R1) | 6.31 | 6.27 | 6.16 | 6.27 | 6.67 |
| Pivot Point | 6.01 | 6.01 | 5.94 | 5.99 | 6.01 |
| Support 1 (S1) | 5.62 | 5.75 | 5.47 | 5.58 | 5.17 |
| Support 2 (S2) | 5.32 | 5.58 | 5.30 | 5.12 | |
| Support 3 (S3) | 4.93 | 5.32 | 5.06 | ||
| Support 4 (S4) | 4.89 |
